Core Points - The Annual General Meeting (AGM) of Anoto Group AB was held on June 27, 2025, where several key decisions were made regarding the company's financials, board elections, and incentive programs [1] Financial Resolutions - The AGM adopted the balance sheet and income statement for 2024, and resolved that no dividend will be distributed, with unrestricted equity carried forward [2] Board Elections and Auditor Appointment - The AGM discharged the Board members and CEO from liability for 2024, re-elected Kevin Adeson, Alexander Fällström, Gary Stolkin, and Adrian Weller to the Board, and elected Matthew Doerner. Kevin Adeson was re-elected as Chairman, and BDO Mälardalen AB was re-elected as auditor [3] Remuneration Guidelines - The AGM adopted the Board of Directors' proposal for guidelines on remuneration to senior executives and approved the remuneration report [4] Long-term Incentive Program (LTIP 2025) - A long-term incentive program (LTIP 2025) was proposed to enhance the company's ability to retain and recruit qualified personnel, consisting of stock options for management and key employees [5] - LTIP 2025 will include a maximum of 275,000,000 new stock options, representing approximately 20.0% of the share capital and votes post-dilution, with performance conditions based on average growth of net sales [6] Stock Option Details - Each stock option allows the holder to acquire one ordinary share during a specified period at an exercise price of 150% of the average volume-weighted share price prior to the AGM, with specific price limits for options granted by the end of July 2025 [7] Share Issuance and Repurchase Authorizations - The AGM authorized the Board to issue up to 275,000,000 Series C shares, deviating from shareholders' preferential rights, to ensure delivery of shares for incentive programs and secure liquidity for social security payments [8] - The Board was also authorized to repurchase Series C shares at a price corresponding to their quota value for similar purposes [10] - Additionally, the AGM approved the delivery of ordinary shares to LTIP 2025 participants and authorized the transfer of shares to secure liquidity for social security charges [11] New Share Issuance Authorization - The AGM authorized the Board to issue new shares, warrants, and/or convertible bonds, allowing for a maximum of 275,000,000 ordinary shares, corresponding to a dilution of approximately 20.0% of the share capital and votes [12]

Exercise of employee share options BW Offshore has completed an exercise window under its Long-Term Incentive Program (LTIP), during which a total of 400,852 vested options were exercised. The company's obligation under the program was settled using existing treasury shares. A third-party conducted sale process has now concluded, with the shares sold at a price of NOK 32.73 each. No primary insiders of the Company have exercised any options in this exercise window. BW Offshore holds 3,740,585 treasury share ...

Stockholm, Sweden--(Newsfile Corp. - May 28, 2025) - The shareholders of Eco Wave Power Global AB (publ), (NASDAQ: WAVE), reg. no. 559202-9499 (the "Company" or "EcoWave"), are hereby given notice to attend the annual general meeting at 10:00 a.m. CEST on Monday June 30, 2025. The meeting will be held at Setterwalls Advokatbyrå's offices at address Sturegatan 10 in Stockholm. Registration for the meeting commences 30 minutes before the opening of the meeting.NoticeShareholders wishing to participate at the ...

Core Points - The Annual General Meeting (AGM) of Anoto Group AB is scheduled for June 27, 2025, at 10 a.m. in Stockholm, Sweden [1] - Shareholders must notify their participation by June 23, 2025, and those holding shares in a nominee's name must re-register their shares by June 18, 2025 [2][3][6] Participation and Proxies - Shareholders wishing to attend the AGM must provide their name, social security number, and registered number of shares via email [2] - Proxies must submit a written power of attorney along with their notification [4] Proposed Agenda - The agenda includes the election of a Chairman, approval of the agenda, presentation of the Annual Report, and resolutions on profit appropriation, discharge of liability for Board members, and remuneration for Board members and auditors [7] Principal Shareholders' Proposals - The Principal Shareholders propose Jörgen S. Axelsson as Chairman of the Meeting [8] - They also propose a Board of Directors consisting of four members and a total remuneration of SEK 1,800,000 [9][10] Board of Directors' Proposals - The Board proposes no dividend distribution for the financial year 2024, with profits carried forward [13] - Guidelines for remuneration to senior executives are proposed to attract and retain competent personnel [14][15] Long-term Incentive Program (LTIP 2025) - The Board proposes a long-term incentive program for management and key employees, consisting of stock options [31] - The program aims to improve retention and motivation among the management team [44] - The maximum number of stock options proposed is 275,000,000, corresponding to approximately 20.0% of the share capital after dilution [33] Share Issuance and Repurchase - The Board seeks authorization to issue up to 275,000,000 Series C shares and to repurchase Series C shares to secure liquidity for incentive programs [47][50] - A resolution for share issuance requires at least two-thirds approval from shareholders [58] Other Information - As of May 28, 2025, the total number of ordinary shares in the Company was 1,102,362,753 [61]

Core Points - The Annual General Meeting (AGM) of Husqvarna AB was held on April 29, 2025, where shareholders could attend physically or via advance voting [1] - The profit and loss statements and balance sheets were adopted, with a dividend of SEK 1.00 per share approved, to be paid in two installments [1] - The Board of Directors' proposal for the composition of the Board was approved, with nine members elected, including new members Claes Boustedt, Marlies Gebetsberger, and Magnus Jarlegren [2] - The total remuneration for the Board was set at SEK 8,490,000, with specific amounts allocated to the Chair and other members [3] - KPMG was elected as the auditor for the period until the next AGM, with fees based on approved invoices [4] - The AGM approved the renewal of remuneration guidelines for Group Management and the Remuneration Report [5] - A performance-based long-term incentive program for 2025 was approved, along with authorization for equity swap arrangements to hedge obligations [6] - The Board was authorized to issue up to approximately 57.6 million new B-shares for acquisitions, with pricing based on market value [7] Company Overview - Husqvarna Group is a global leader in innovative solutions for managing forests, parks, and gardens, as well as cutting equipment and diamond tools for construction and stone industries [9] - The company reported net sales of SEK 48.4 billion in 2024 and employs approximately 12,300 people in 40 countries [9]

Core Viewpoint - Zealand Pharma A/S has announced the implementation of long-term incentive programs for 2025 aimed at aligning the interests of its Board of Directors, Corporate Management, and employees with those of shareholders, while also attracting and retaining top talent [1][2]. Long-term Incentive Program - The long-term incentive program includes the granting of restricted share units (RSUs) and performance share units (PSUs) to various stakeholders within the company [2][10]. - The program is designed to align with selected European and U.S. biotech peers and to drive long-term performance [2]. Board of Directors - A total of 29,169 RSUs have been awarded to Zealand Pharma's Board of Directors, with vesting occurring annually in equal tranches over three years [10][5]. - The maximum number of RSUs granted to any Board member is capped at 8,000, with specific monetary limits based on their roles [6]. - Board members are required to hold RSUs equivalent to 200% of their annual grant value within two years of their election [7]. Corporate Management - Zealand Pharma's Corporate Management has been awarded 96,788 PSUs and 96,788 RSUs, with an estimated fair market value of DKK 82.2 million [10][13]. - The PSUs vest based on predefined performance targets, with potential vesting ranging from 0% to 150% after three years [11][12]. - RSUs for Corporate Management will vest annually in equal tranches over three years [12]. Employee Grants - US employees have been awarded 18,502 RSUs, while employees in Denmark have received 128,519 RSUs, with respective estimated fair market values of DKK 7.9 million and DKK 54.6 million [10][17][20]. - RSUs for US employees and employees in Denmark will vest annually in equal tranches over three years, with conditions tied to continued employment [16][19]. Company Overview - Zealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines, with over 10 drug candidates in clinical development [22]. - The company has established partnerships with several major pharmaceutical companies and has a presence in both Denmark and the United States [22][23].